Informa
TIDES Asia: Oligonucleotide & Peptide Therapeutics
2025年2月26-28日
日本京都, Westin Miyako Kyoto

主会议 第2天

主会议 第2天

7:45am - 8:10am25分钟
Registration and Coffee
报到・咖啡时光
    8:10am - 8:15am5分钟
    Chairperson’s Remarks: Plenary Day 2
    主席致辞：主题讲演（第2天）
      8:15am - 8:45am30分钟
      Morning Spotlight Presentation: Isolation and Drying of Peptides and 0ligonucleotides - Improved Production Capacities During Large Scale Manufacturing
      晨间焦点简报：胜肽和寡核苷酸的分离和干燥—提高大规模生产过程中的生产能力
      • Keith Cronce - Chief Operating Officer, Fluid Air, A Division of Spraying Systems
      Plenary Session
      主题讲演单元
      8:45am - 9:15am30分钟
      Plenary Session
      主题讲演单元
      Complete Chemical Synthesis of mRNA for Cancer Vaccine
      癌症疫苗 mRNA 的完整化学合成
      • Hiroshi Abe, PhD - Professor, Department of Chemistry, Graduate School, Nagoya University
      9:15am - 9:45am30分钟
      Plenary Session
      主题讲演单元
      Developing the Next Generation RSV Vaccine
      下一代 RSV 疫苗的开发
      • Dong Shen, MD, PhD - CEO, RNAimmune, Inc.
      9:45am - 10:15am30分钟
      Plenary Session
      主题讲演单元
      RNA Therapy for Asthma
      哮喘的 RNA 疗法
      • Thomas Langenickel, MD, PhD - Chief Medical Officer, Ethris GmbH
      10:15am - 10:55am40分钟
      Networking Refreshment Break with Poster and Exhibit Viewing
      互动交流休息时间，观赏海报和展览
        Concurrent Conference Tracks
        同时进行的各个分会
        10:55am - 11:00am5分钟
        Track 1: Oligonucleotides
        分会1：寡核苷酸
        Chairperson’s Remarks: Track 1
        主席致辞：分会1
        • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
        10:55am - 11:00am5分钟
        Track 2: Peptides
        分会2：胜肽
        Chairperson’s Remarks: Track 2
        主席致辞：分会2
        • El Djouhar Rekai, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
        11:00am - 11:30am30分钟
        Track 1: Oligonucleotides
        分会1：寡核苷酸
        CMC Strategies for the Characterization of Stereopure Platform Chemistry
        用于表征立体纯平台化学的 CMC 策略
        • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
        11:00am - 11:30am30分钟
        Track 2: Peptides
        分会2：胜肽
        Industry Perspective on the Selection of Regulatory Starting Materials for Synthetic Peptides
        关于如何选择监管对象合成肽起始材料的业界见解
        • John Lopez, PhD - Associate Director Science & Technology, Novartis
        11:30am - 12:00pm30分钟
        Track 1: Oligonucleotides
        分会1：寡核苷酸
        Template-independent Enzymatic Synthesis of Natural and Fully Modified siRNA Oligonucleotides
        天然/完全修饰的 siRNA 寡核苷酸的不依赖模板的酶合成
        • Jonathan Rittichier, PhD - Chief Scientific Officer & Co-Founder, EnPlusOne BioSciences
        11:30am - 12:00pm30分钟
        Track 2: Peptides
        分会2：胜肽
        Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase
        原料药中的杂质以及申请（美国、欧盟、巴西和中国市场）和商业化阶段面临的课题
        • Dinesh Parmar - Associate Director Regulatory Affairs, PolyPeptide Group
        12:00pm - 12:30pm30分钟
        Track 1: Oligonucleotides
        分会1：寡核苷酸
        Synthesis of Nucleic Acid Therapeutics: Next Generation Processes and Solutions
        核酸治疗药物的合成：下一代制程和解决方案
        • Sirat Sikka - Senior Scientist, Applications and Innovation, Thermo Fisher Scientific
        12:00pm - 12:30pm30分钟
        Track 2: Peptides
        分会2：胜肽
        Statistical Design of Experiments in Peptide Process Development
        胜肽制程开发中实验的统计设计
        • Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
        12:30pm - 1:40pm70分钟
        Networking Luncheon with Poster and Exhibit Viewing
        交流时间・午餐会，观赏海报和展览
          1:40pm - 1:45pm5分钟
          Track 1: Oligonucleotides
          分会1：寡核苷酸
          Chairperson’s Remarks: Track 1
          主席致辞：分会1
          • Sridhar Vaddeboina, Ph.D. - Vice President, Analytical Development, Wave Life Sciences
          1:40pm - 1:45pm5分钟
          Track 2: Peptides
          分会2：胜肽
          Chairperson’s Remarks: Track 2
          主席致辞：分会2
            1:45pm - 2:15pm30分钟
            Track 1: Oligonucleotides
            分会1：寡核苷酸
            Drug Substance and Drug Product CMC Strategies for Start-Ups and Smaller Companies
            新创公司和小型公司的原料药和药品 CMC 策略
            • Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
            1:45pm - 2:15pm30分钟
            Track 2: Peptides
            分会2：胜肽
            Development of an Efficient and Scalable CSPS Process for a Mid-Sized Cyclic Peptide
            开发适用于中型环肽的高效且可扩大缩小的 CSPS 制程
            • Hiroshi Iwamura, PhD - Deputy Head of API Process Development Department, Chugai Pharmaceutical Co., Ltd.
            2:15pm - 2:45pm30分钟
            Track 1: Oligonucleotides
            分会1：寡核苷酸
            Oligonucleotide API Quality
            寡核苷酸API的品质
              2:15pm - 2:45pm30分钟
              Track 2: Peptides
              分会2：胜肽
              Overcoming Aggregation Challenges in Peptide Manufacturing: Technical Approach and Case Studies
              克服胜肽生产过程中的聚集问题：技术方法与案例研究
              • El Djouhar Rekai, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
              2:45pm - 3:15pm30分钟
              Track 1: Oligonucleotides
              分会1：寡核苷酸
              Oligonucleotide Process Validation
              寡核苷酸制程验证
                2:45pm - 3:15pm30分钟
                Track 2: Peptides
                分会2：胜肽
                An Inline Monitoring Method Integrated Flow Chemistry for Peptide Synthesis and Manufacturing
                用于胜肽合成和制造的整合流动化学线上监测方法
                • Pengyu Xu, PhD - President and Representative Director, SynCrest Inc.
                3:15pm - 3:45pm30分钟
                Networking Refreshment Break with Poster and Exhibit Viewing
                互动交流休息时间，观赏海报和展览
                  3:45pm - 4:15pm30分钟
                  Track 1: Oligonucleotides
                  分会1：寡核苷酸
                  Development of a Kilogram-Scale Manufacturing Route for Guadecitabine: A Dinucleotide DNA Methyltransferase Inhibitor
                  Guadecitabine公斤级生产方法的开发：一种二核苷酸 DNA 甲基转移酶抑制剂
                  • Yogesh Sanghvi, PhD - President, Rasayan Inc.
                  3:45pm - 4:15pm30分钟
                  Track 2: Peptides
                  分会2：胜肽
                  GLP-1 Process Development and Manufacturing
                  GLP-1工程的开发与制造
                    4:15pm - 4:45pm30分钟
                    Track 1: Oligonucleotides
                    分会1：寡核苷酸
                    Analytical Strategies for RNA Therapeutics
                    RNA治疗药的分析策略
                      4:15pm - 4:45pm30分钟
                      Track 2: Peptides
                      分会2：胜肽
                      Liquid-phase Peptide Fragment Manufacturing Technologies and Workflows
                      液相肽片段的生产技术和工作流程
                      • Adrian Amador, PhD - Director of Process Chemistry, Cambrex
                      4:45pm - 5:15pm30分钟
                      Track 1: Oligonucleotides
                      分会1：寡核苷酸
                      Oligonucleotide Purification and CMC Strategies - Increasing Efficiencies/Overcoming Challenges
                      寡核苷酸纯化和 CMC 策略：提高效率并克服课题
                      • Robert Gronke, PhD - Senior Principal Scientist, Technical Development, Biogen, Inc
                      4:45pm - 5:15pm30分钟
                      Track 2: Peptides
                      分会2：胜肽
                      Late Breaking Presentation
                      发表最新成果
                        5:15pm - 6:15pm60分钟
                        Networking Cocktail Reception with Poster and Exhibit Viewing
                        社交鸡尾酒会，观赏海报和展览
                          6:15pm - 6:20pm5分钟
                          Close of Day Two
                          第2天结束
                            会前研讨会 (上午) & 主会议 第1天 (下午)
                            Next主会议 第3天

                            * 活动内容有可能不事先告知作更动及调整。